Anti-Nrf2 antibody [EP1808Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(34 Reviews)
|
(799 Publications)
Anti-Nrf2 antibody [EP1808Y] (ab62352) is a rabbit monoclonal antibody detecting Nrf2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, ICC/IF. Suitable for Human.
- Clone EP1808Y is the most cited clone to Nrf2
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 580 publications
View Alternative Names
NRF2, NFE2L2, Nuclear factor erythroid 2-related factor 2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2
- WB
Lab
Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
False colour image of Western blot : Anti-Nrf2 antibody [EP1808Y] - ChIP Grade staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab62352 was shown to bind specifically to Nrf2.
Target band (indicated by arrow) was observed at 85-90 kDa in wild-type A549 cell lysates with no signal observed at this size in NFE2L2 knockout cell line ab285359 (knockout cell lysate ab289682). A band lower than the target was present on both WT and KO. According to the literature (PMID : 40043449), the lower band is calmegin.
To generate this image, wild-type and NFE2L2 knockout A549 cell lysates were analysed. Please note that MG132 treatment does not affect expression levels of Nrf2. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/1000 dilution
Lane 1:
Wild-type A549 Vehicle control MG132 (0 uM, 18 h) cell lysate at 20 µg
Lane 2:
Wild-type A549 Treated MG132 (2 uM, 18 h) cell lysate at 20 µg
Lane 3:
NFE2L2 [21] knockout A549 Vehicle control MG132 (0 uM, 18 h) cell lysate at 20 µg
Lane 4:
NFE2L2 [21] knockout A549 Treated MG132 (2 uM, 18 h) cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 68 kDa
false
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
ab62352 staining Nrf2 in untreated wild type A549 cells (left panel), treated wild type A549 cells (middle panel) and untreated NFE2L2 knockout A549 cells (right panel). Cells were treated with 2µM of MG-132 for 18 hours (ab141003). The cells were fixed with 4% paraformaldehyde (10 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab62352 at 0.2 µg/ml concentration and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2µg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2µg/ml (shown in magenta). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Nrf2 antibody [EP1808Y] (AB62352)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labelling Nrf2 with ab62352 at 1/40 (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. An Alexa Fluorr®488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Nrf2 antibody [EP1808Y] (AB62352)
Intracellular Flow Cytometry analysis of HeLa cells labelling Nrf2 with purified ab62352 at a dilution of 1/60 (red). Cells were fixed with 4% paraformaldehyde. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG (ab172730). Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
ab62352 staining Nrf2 in untreated HeLa cells (top panel) and treated HeLa cells (bottom panel). Cells were treated with 2μM of MG-132 for 18 hours (ab141003). The cells were fixed with 4% paraformaldehyde (10 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab62352 at 1μg/ml concentration and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
Immunocytochemistry/Immunofluorescence analysis of HepG2 cells labelling Nrf2 with purified ab62352 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. The cells were co-stained with ab195889, an Alexa Fluor® 594-conjugated mouse anti-alpha tubulin antibody (1/200). Nuclei counterstained with DAPI (blue).
Secondary antibody only control : PBS was used instead of the primary antibody as the negative control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
Immunocytochemistry/Immunofluorescence analysis of HeLa cells labelling Nrf2 with purified ab62352 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (1/1000) was used as the secondary antibody. Cells were counterstained with ab195889, anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594). DAPI was used to stain the nuclei blue.
Secondary antibody only control : PBS was used instead of the primary antibody as the negative control.
- WB
Lab
Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
False colour image of Western blot : Anti-Nrf2 antibody [EP1808Y] - ChIP Grade staining at 1/500 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab62352 was shown to bind specifically to Nrf2. A band was observed at 85 kDa in wild-type HeLa cell lysates with no signal observed at this size in NFE2L2 knockout cell line ab262507 (knockout cell lysate ab263934). The band observed in the knockout lysate lane below 85 kDa is likely to represent a truncated form of Nrf2. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and NFE2L2 knockout HeLa cell lysates were analysed.First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/500 dilution
Lane 1:
Western blot - Human NFE2L2 (Nrf2) knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-nfe2l2-nrf2-knockout-hela-cell-lysate-ab263934'>ab263934</a>)
Lane 1:
Wild-type HeLa control MG132 (0 uM, 18 h) cell lysate
Lane 2:
Wild-type HeLa treated MG132 (2 uM, 18 h) cell lysate
Lane 2:
Western blot - Human NFE2L2 (Nrf2) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-nfe2l2-nrf2-knockout-hela-cell-line-ab262507'>ab262507</a>)
Lane 3:
NFE2L2 knockout HeLa control MG132 (0 uM, 18 h) cell lysate
Lane 4:
NFE2L2 knockout HeLa treated MG132 (2 uM, 18 h) cell lysate
Lane 5:
HCT 116 cell lysate
false
- WB
Lab
Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
The expression of Nrf2 is stimulated by oxidative stress, electrophiles and chemical activators (PMID : 25761198, PMID : 27638861 and PMID : 28587109). ab62352 detects no signal in most of the untreated samples in WB. Stimuli treated samples are recommended.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/200 dilution
Lane 1:
HCT 116 (Human colorectal carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
HCT 116 (Human colorectal carcinoma epithelial cell) treated with 25uM MG-132 for 4 hours whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 68 kDa
Observed band size: 100 kDa
false
Exposure time: 60s
- WB
AbReview81245****
Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
Western blot analysis using ab62352 at 1 : 1000 on Human iPSC-cardiomyocytes. Blocking agent and dilution buffer was 5% Skim Milk in TBS-Tween.
A cellular fractionation in Human iPSC-cardiomyocyte cells was performed to separate the nucleus from the cytoplasm (Lane 2).
All lanes:
Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/1000 dilution
Lane 1:
Human iPSC-cardiomyocytes cytoplasmatic fraction, at 20 µg
Lane 2:
Human iPSC-cardiomyocytes nuclear fraction at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab6721'>ab6721</a>) at 1/2000 dilution
Observed band size: 100 kDa
false
Related conjugates and formulations (6)
-
578 PE
PE Anti-Nrf2 antibody [EP1808Y]
-
660 APC
APC Anti-Nrf2 antibody [EP1808Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Nrf2 antibody [EP1808Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Nrf2 antibody [EP1808Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Nrf2 antibody [EP1808Y]
-
Anti-Nrf2 antibody [EP1808Y] - BSA and Azide free
Reactivity data
Product details
Anti-Nrf2 antibody [EP1808Y] (ab62352) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF and WB.
Anti-Nrf2 antibody [EP1808Y] (ab62352) was first used in a scientific publication in 2009 and has been cited over 584 times in peer reviewed journals. It's performance in Western Blot in human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-Nrf2 antibody [EP1808Y] (ab62352) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Nrf2 antibody [EP1808Y] (ab62352) has been confirmed by Western Blot testing in Nrf2 knockout HeLa cells (ab262507).
Anti-Nrf2 antibody [EP1808Y] (ab62352) has 28 independent reviews from customers.
Anti-Nrf2 antibody [EP1808Y] (ab62352) specifically detects Nrf2 (UniProt ID: Q16236; Molecular weight: 68kDa) and is sold in 100 µL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EP1808Y - ab180845.
Antibody clone EP1808Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 594, PE, APC (ab194984, ab194985, ab206890, ab223926, ab223927).
NRF2 is a pivotal transcription factor in neuro research, known for regulating cellular defense mechanisms. It supports mitochondrial function and protects against oxidative damage, which is crucial for brain health. NRF2 also modulates glial inflammatory responses, playing a significant role in preventing neuroinflammation. Researchers use NRF2 to study oxidative stress, inflammation and neuroprotection, making it essential for understanding and potentially treating neurodegenerative diseases.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nrf2 acts as an important regulator of the cellular antioxidant response. It works in conjunction with its partner protein Keap1 forming a complex that controls its stability and degradation. Under normal conditions Keap1 keeps Nrf2 in the cytoplasm where it is targeted for ubiquitination and degradation. Once activated by oxidative stress or electrophiles Nrf2 dissociates from Keap1 thereby avoiding degradation and relocates to the nucleus to activate the transcription of ARE-dependent genes. This activity boosts the cellular response to oxidative stress by inducing genes involved in detoxification and cellular defense.
Pathways
Nrf2 plays a significant role in the oxidative stress response and detoxification pathways. Nrf2 activation is linked closely to the PI3K/Akt signaling pathway which influences cell survival growth and metabolism. This pathway also interacts with other important proteins like GSK-3β which can modulate Nrf2 activity and stability. Through these pathways Nrf2 orchestrates a defense mechanism against reactive oxygen species (ROS) by boosting the expression of antioxidant enzymes and detoxifying proteins.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (799)
Recent publications for all applications. Explore the full list and refine your search
European journal of histochemistry : EJH 69: PubMed41036671
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 18:213 PubMed41029755
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 53: PubMed41020501
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2025:4932970 PubMed40918406
2025
Applications
Unspecified application
Species
Unspecified reactive species
Medical oncology (Northwood, London, England) 42:456 PubMed40883565
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical, cosmetic and investigational dermatology 18:1971-1983 PubMed40860313
2025
Applications
Unspecified application
Species
Unspecified reactive species
Orphanet journal of rare diseases 20:453 PubMed40849475
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:380 PubMed40813365
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:616 PubMed40796730
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical biochemistry and nutrition 77:30-36 PubMed40777822
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com